Results 201 to 210 of about 7,072 (218)

Non-eligibility for pivotal HFpEF/HFmrEF outcome trials and mortality in a contemporary heart failure cohort

European Journal of Internal Medicine, 2023
Markus Wallner, Peter P Rainer, Ewald Kolesnik   +2 more
exaly  

HFmrEF in elderly patients hospitalised for acute heart failure: data from the ATHENA registry

2017
Our study shows that in real world setting of elderly admitted for AHF, HFmrEF patients are significantly represented, with clinical and demographic characteristics similar to patients with HFpEF, except for the ischemic feature that seems to bring them closer to patients with HFrEF.
Parlapiano, S, Baldasseroni, S, Herbst, A, Pratesi, A, Bacci, F, Tozzetti, C, Ghiara, C, Ciuti, G, Baglioni, G, Poggesi, L, Nozzoli, C, Pignone, AM, Gabbani, L, Marchionni, N, Orso, F   +14 more
openaire   +2 more sources

Ejection fraction at hospital admission stratifies mortality risk in HFmrEF patients aged ≥ 70 years: a retrospective analysis from a tertiary university institution

Aging Clinical and Experimental Research, 2023
exaly  

Patients with HFpEF and HFmrEF have different clinical characteristics in Turkey: A multicenter observational study

European Journal of Internal Medicine, 2019
Bülent Özlek, Serkan Kahraman, OĞuzhan Çelİk   +2 more
exaly  

Hat die HFmrEF bald ausgedient?

CardioVasc
openaire   +1 more source

Age-dependent differences in clinical phenotype and prognosis in heart failure with mid-range ejection compared with heart failure with reduced or preserved ejection fraction

Clinical Research in Cardiology, 2019
Xiaojing Chen, Gianluigi Savarese, Ulf Dahlstrom   +2 more
exaly  

Prevalence And Clinical Significance Of Systemic Inflammation In Hfpef And Hfmref

Journal of Cardiac Failure
Barry A. Borlaug, Cecile Holse, Mette Holme Jung, A. Michael Lincoff, Sharon Mulvagh, Jacob Stærk-Østergaard, Katherine Tuttle, Mark Petrie   +7 more
openaire   +1 more source

Weitere Therapieoption: Finerenon wirkt bei HFmrEF und HFpEF

CardioVasc
openaire   +1 more source

TAPSE/PASP ratio as a prognostic marker in HFmrEF: a missed opportunity?

Heart and Vessels
Xiaoyan Chen, Youai Xie, Meiqing Zhou
openaire   +1 more source

Herzinsuffizienz mit eingeschränkter LVEF (HFrEF, HFmrEF)

openaire   +1 more source